BoomRx pricing vs pass-through alternatives

BoomRx pricing vs pass-through: which model fits a clinic?

BoomRx uses a portal-gated model: competitive pricing across 503A, 503B, and brand partners with a $30 flat cold-chain shipping fee per patient order, confirmed after provider signup. A pass-through alternative shows resolved per-vial 503A cost on each line before checkout with a disclosed fee. The economic difference is timing and verifiability — portal pricing can win on network-scale buying, while pass-through wins on cost visibility before you order and quote patients.

This page compares the two pricing economies head to head and explains which clinic profiles each model fits best.

Compare Fizy Health vs BoomRx

Proudly Partnered With

Two pricing economies, compared

A portal-gated model and a pass-through model solve the same problem — getting compounded medications to a clinic at a competitive price — through opposite mechanics. BoomRx consolidates buying across 503A, 503B, and brand partners and delivers rates in a provider dashboard after signup, so the strength is network-scale procurement with predictable $30 flat cold-chain shipping per patient order and the cost is that you cannot see or verify the number until after onboarding. A pass-through model shows the 503A drug cost per vial on each line before checkout and names a separate facilitation fee, so the strength is visibility and verifiability and the trade-off is that it focuses on 503A patient-specific checkout rather than 503B breadth.

Where each model wins on economics

Portal-gated pricing can win when a clinic values one login across 503A, 503B, and brand medications, when flat $30 cold-chain shipping per patient order simplifies ops planning, and when network-scale buying delivers competitive rates at the buyer's volume. The risk is that the rate is unverifiable up front and may pair with platform fees that change total cost of ownership. Pass-through pricing wins when a clinic needs to quote cash-pay patients on landed cost before the consult, wants to verify that drug cost is not marked up, batches patient-specific 503A refills in one cart, and values seeing the number on every SKU before ordering.

Most cash-pay clinics care most about one thing: knowing per-vial cost before they set patient pricing. That single requirement tends to favor a pass-through model, because portal rates that arrive after signup cannot inform pricing you need to set during evaluation. But a clinic that relies on 503B office-use SKUs or needs EMR integrations from a procurement hub may rationally prefer BoomRx — the right answer depends on the clinic, not the marketing.

How to run the comparison on your own numbers

Do not decide on model labels; decide on landed cost for your real SKUs. Complete BoomRx provider signup or request written per-vial cost on your top three SKUs, add the $30 shipping fee per patient order, and confirm any separate platform or processing fees. Then open a pass-through catalog and read the visible per-vial cost plus disclosed facilitation fee on the same drug, strength, and vial size. Normalize both to delivered per-vial cost over a representative month.

With Fizy Health you can do half of that comparison immediately, because it shows resolved per-vial 503A cost on each catalog and cart line before checkout and discloses a single facilitation fee at payment. Build a representative cart, read the totals, and set that against BoomRx portal rates after signup. Whichever model delivers lower true landed cost on the SKUs you actually order is the right choice — and now you can prove it rather than assume it.

Network procurement economics — or visible pass-through economics?

BoomRx fits if

BoomRx

Your clinic needs unified 503A, 503B, and brand procurement.

  • You want one portal across 503A, 503B, and brand medications with $30 flat cold-chain shipping per patient order.
  • You are comfortable confirming per-vial cost after provider signup rather than before.
  • EMR or API integrations from a procurement hub matter more than patient-linked batch checkout.
Consider Fizy Health if

Fizy Health

You want visible, verifiable 503A cost before you order.

  • You quote cash-pay patients and need per-vial 503A cost before the consult, not after signup.
  • You batch dozens of patient-specific refills and want one HIPAA-audited cart with cost on every line.
  • You want to compare landed cost on your real SKUs before committing to a pricing model.
FAQ

What clinics ask about BoomRx vs pass-through pricing.

  • Models

    What is the difference between portal-gated and pass-through pricing?

    Portal-gated pricing appears after signup in a vendor dashboard. Pass-through pricing shows partner pharmacy drug cost per vial on each line before checkout with a separately disclosed platform fee.

  • Economics

    When does BoomRx pricing win economically?

    When unified 503A, 503B, and brand procurement, $30 flat shipping per patient order, and network-scale buying deliver lower all-in landed cost at your volume — confirmed after signup, not assumed from marketing.

  • Economics

    When does pass-through pricing win economically?

    When you need per-vial 503A cost visible before the consult, batch patient-specific refills in one cart, and verify drug cost is not marked up before you commit.

  • 503B

    Does pass-through pricing include 503B like BoomRx?

    Fizy Health routes patient-specific orders to LegitScript-certified 503A partners. BoomRx also surfaces 503B products. If your formulary relies on 503B office-use SKUs, confirm fit before switching.

  • Method

    How should I run a fair pricing comparison?

    Normalize to delivered per-vial cost on your top three SKUs. Add BoomRx dashboard rate, $30 shipping per patient order, and any confirmed fees; compare against visible pass-through cost plus disclosed facilitation fee.

  • Coexistence

    Can I use both BoomRx and a pass-through platform?

    Yes. Many clinics run one refill week on both workflows before choosing a primary path. BoomRx for 503B and brand procurement; Fizy Health for patient-linked 503A batch checkout with visible pricing.

Sources reviewed June 2026

  • BoomRx public website (boomrx.com), reviewed June 2026.
  • BoomRx press release via PR Newswire (Dec 2025), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Prove which pricing model wins on your SKUs.

Read pass-through per-vial cost now, compare against BoomRx portal rates on one refill week, and decide on delivered numbers. Free to start.